Xavier Guille des Buttes
Direttore/Membro del Consiglio presso GENFIT
Patrimonio netto: 9 438 $ in data 31/05/2024
Profilo
Xavier Guille des Buttes is currently the Vice Chairman at Genfit SA since 2017.
He is also the Chairman at Université Catholique de Lille, Director at Hemarina SA, Director at IBA Molecular Holding SA, Director at Somedial SpA, and a Member-Partners Board at Delpharm SAS.
Previously, he served as the Chairman-Management Board at Bayer Schering Pharma AG in 2006.
He has also held positions as a Director at Delpharm Holding SASU, Member-Supervisory Board at Financière Delpharm SAS, Member-Supervisory Board at DIAGAST SAS, and Member-Supervisory Board at Ouest Angels Developpment SAS.
Mr. Guille des Buttes completed his undergraduate degree at Institut de Contrôle de Gestion, L'Ecole Superieure des Sciences Commerciales d'Angers, and Institut Supérieur de Commerce International de Dunkerque.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GENFIT SA
0.00% | 01/04/2024 | 1 842 ( 0.00% ) | 9 438 $ | 31/05/2024 |
Posizioni attive di Xavier Guille des Buttes
| Società | Posizione | Inizio |
|---|---|---|
| GENFIT | Direttore/Membro del Consiglio | 16/06/2017 |
| Somedial SpA | Direttore/Membro del Consiglio | 19/07/2010 |
Hemarina SA
 Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Direttore/Membro del Consiglio | - |
Delpharm SAS
 Delpharm SAS Pharmaceuticals: MajorHealth Technology Delpharm SAS develops and manufactures drugs. The company is headquartered in Issy-les-Moulineaux, France. | Corporate Officer/Principal | - |
| Université Catholique de Lille | Presidente | - |
IBA Molecular Holding SA
 IBA Molecular Holding SA Pharmaceuticals: MajorHealth Technology IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium. | Direttore/Membro del Consiglio | 17/03/2006 |
Precedenti posizioni note di Xavier Guille des Buttes
| Società | Posizione | Fine |
|---|---|---|
| Bayer Schering Pharma AG | Amministratore Delegato | 01/06/2006 |
Delpharm Holding SASU
 Delpharm Holding SASU Pharmaceuticals: MajorHealth Technology Delpharm Holding SASU was engaged in pharmaceutical development and contract manufacturing services. Its activities included secondary manufacturing and processing, packaging and labeling of finished products, and branded prescription products. The company was founded on March 29, 2011 and was headquartered in Boulogne-Billancourt, France. | Direttore/Membro del Consiglio | - |
Ouest Angels Developpment SAS
 Ouest Angels Developpment SAS Financial ConglomeratesFinance Ouest Angels Developpment operates as a business organization, with interest in the promotion of equity, start-up, and other private investment activities. The company was founded by Henry De Champsavin in 2007 and is headquartered in Nantes, France. | Direttore/Membro del Consiglio | - |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Xavier Guille des Buttes
| Institut de Contrôle de Gestion | Undergraduate Degree |
| L'Ecole Superieure des Sciences Commerciales d'Angers | Undergraduate Degree |
| Institut Supérieur de Commerce International de Dunkerque | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENFIT | Health Technology |
| Aziende private | 9 |
|---|---|
| Bayer Schering Pharma AG | Health Technology |
Delpharm Holding SASU
Delpharm Holding SASU Pharmaceuticals: MajorHealth Technology Delpharm Holding SASU was engaged in pharmaceutical development and contract manufacturing services. Its activities included secondary manufacturing and processing, packaging and labeling of finished products, and branded prescription products. The company was founded on March 29, 2011 and was headquartered in Boulogne-Billancourt, France. | Health Technology |
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Health Technology |
IBA Molecular Holding SA
IBA Molecular Holding SA Pharmaceuticals: MajorHealth Technology IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
DIAGAST SAS
 DIAGAST SAS Pharmaceuticals: MajorHealth Technology DIAGAST SAS operates as a blood matching company. Its products include QWALYS range, Erythrocytes Magnetized technology, manual range, PK 7300 ranges, pre-transfusion control, disposable plates and technical inserts. The company was founded in 1968 and is headquartered in Loos, France. | Health Technology |
| Somedial SpA | |
Ouest Angels Developpment SAS
Ouest Angels Developpment SAS Financial ConglomeratesFinance Ouest Angels Developpment operates as a business organization, with interest in the promotion of equity, start-up, and other private investment activities. The company was founded by Henry De Champsavin in 2007 and is headquartered in Nantes, France. | Finance |
Delpharm SAS
Delpharm SAS Pharmaceuticals: MajorHealth Technology Delpharm SAS develops and manufactures drugs. The company is headquartered in Issy-les-Moulineaux, France. | Health Technology |
Financière Delpharm SAS
 Financière Delpharm SAS Pharmaceuticals: MajorHealth Technology Financière Delpharm SAS operates as a holding company with interests in the manufacturing of pharmaceuticals. The company was founded on 25 March 2004 and is headquartered in Issy-les-Moulineaux, France. | Health Technology |
- Borsa valori
- Insiders
- Xavier Guille des Buttes
